HLA-DRB1 and myeloid sarcoma: However, the extended DRB1*-DQB1*haplotype has not been taken into account in these studies [13]–[16], despite findings that support the effect of both DRB1*15:01 and DQB1*16:02 alleles [17], [18] in MS risk.